ACADIAN ASSET MANAGEMENT LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 102 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2016$89,000
-85.0%
198,047
-65.1%
0.00%
-100.0%
Q1 2016$595,000
-38.5%
567,542
+72.9%
0.00%
-40.0%
Q4 2015$968,000328,2130.01%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,484,649$7,330,0008.59%
Avoro Capital Advisors LLC 5,144,916$15,178,0005.23%
Broadfin Capital, LLC 6,090,829$17,968,0001.10%
Aisling Capital LLC 2,010,000$5,930,0001.02%
Healthcare Value Capital, LLC 150,000$443,0000.73%
ACUTA CAPITAL PARTNERS, LLC 434,300$1,281,0000.61%
WALL STREET ASSOCIATES 696,300$2,054,0000.58%
SEARLE & CO. 172,500$500,0000.48%
Elk Creek Partners, LLC 2,253,667$6,648,0000.47%
KOPP INVESTMENT ADVISORS LLC 315,293$931,0000.46%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders